Microbiological Appraisal of Levofloxacin Activity AgainstPseudomonas aeruginosaBiofilm in Combination with Different Calcium Channel BlockersIn Vitro
Authors:
- W.F. ElkhatibWEW.F. Elkhatib
- V.L. HaynesVHV.L. Haynes
- A.M. NoreddinANA.M. Noreddin
- 1 April 2009
- journal article
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 21 (2) , 135-143
Abstract
Chronic multi-drug resistant Pseudomonas aeruginosa infections among hospitalized elderly patients are nearly epidemic in some institutions and biofilms are now recognized as the root cause of such chronic infections such as with cystic fibrosis patients. We address the potential risks and advantages of combining commonly prescribed calcium channel blockers (CCBs) with the fluoroquinolone levofloxacin in the treatment of P. aeruginosa biofilms by using in vitro real-time monitoring of biofilm growth/inhibition over time. while mibefradil and diltiazem appear to be strongly antagonistic toward antimicrobial activity of levofloxacin, amlodipine and bepridil appear to have significant synergistic effects.Keywords
This publication has 25 references indexed in Scilit:
- Biofilms 2007: Broadened Horizons and New EmphasesJournal of Bacteriology, 2007
- Contributions of the Combined Effects of Topoisomerase Mutations toward Fluoroquinolone Resistance in Escherichia coliAntimicrobial Agents and Chemotherapy, 2007
- Resistance Mechanisms of Multiresistant Pseudomonas aeruginosa Strains from Germany and Correlation with HypermutationAntimicrobial Agents and Chemotherapy, 2007
- Bacteriology of Moderate-to-Severe Diabetic Foot Infections and In Vitro Activity of Antimicrobial AgentsJournal of Clinical Microbiology, 2007
- Optimising Dosing Strategies of Antibacterials Utilising Pharmacodynamic PrinciplesDrugs, 2006
- Bacterial biofilms: from the Natural environment to infectious diseasesNature Reviews Microbiology, 2004
- Hypertension Control in the Elderly with AmlodipineCurrent Medical Research and Opinion, 2000
- Verapamil-Tobramycin Synergy in Pseudomonas cepacia but Not Pseudomonas aeruginosa in vitroChemotherapy, 1995
- BepridilDrugs, 1992
- Berpidil: A pharmacological reappraisal of its potential beneficial effects in angina and tissue protection following ischemiaCardiovascular Drugs and Therapy, 1989